April 24 (Reuters) - Germany's Merck KGaA MRCG.DE is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics SWTX.O, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
(Reporting by Sriparna Roy in Bengaluru; Editing by Alan Barona)
((Sriparna.Roy@thomsonreuters.com))